BXM Wealth’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

BXM Wealth’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,350	Closed	-$3.05K	–	171
2026 Q1	$3.05K	Sell	12,350 -100	-0.8%	-$40	﹤0.01%	131
2025 Q4	$5.23K	Hold	12,450	–	–	﹤0.01%	133
2025 Q3	$8.38K	Sell	12,450 -100	-0.8%	-$54	0.01%	129
2025 Q2	$6.79K	Hold	12,550	–	–	0.01%	108
2025 Q1	$8.23K	Sell	12,550 -6,000	-32%	-$6.35K	0.01%	103
2024 Q4	$18.9K	Buy	+18,550	New	+$33.9K	0.03%	96

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

BXM Wealth's SGMO Position: Q2 2026 in Review

BXM Wealth sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 12,350 shares — an estimated $3.05K sold.

BXM Wealth first reported a position in SGMO in Q4 2024 and held it in 6 quarters. The position peaked at $18.9K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

BXM Wealth reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
BXM Wealth sold 12,350 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.05K.
BXM Wealth first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and held it in 6 quarters.
BXM Wealth's SANGAMO THERAPEUTICS INC position peaked at $18.9K in Q4 2024.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.